|4Jun 1, 7:47 PM ET

VISX INC 4

4 · VISX INC · Filed Jun 1, 2005

Insider Transaction Report

Form 4
Period: 2005-05-27
HOLMES JAY T
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2005-05-273,4800 total
  • Disposition to Issuer

    Phantom Stock (Right to Aquire)

    2005-05-271,7600 total
    Common Stock (1,760 underlying)
  • Disposition to Issuer

    Phantom Stock (Right to Aquire)

    2005-05-271,3140 total
    Common Stock (1,314 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2005-05-2745,0000 total
    Exercise: $49.78Exp: 2009-03-16Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2005-05-2740,0000 total
    Exercise: $6.31Exp: 2008-04-01Common Stock (40,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2005-05-276,0000 total
    Exercise: $20.44Exp: 2010-05-19Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2005-05-2710,0000 total
    Exercise: $17.06Exp: 2013-05-23Common Stock (10,000 underlying)
Footnotes (11)
  • [F1]Disposed of pursuant to merger agreement between issuer and Advanced Medical Optics, Inc. in exchange for 1,920 shares of Advanced Medical Optics, Inc. common stock on the effective date of the merger.
  • [F10]This option, which was fully vested as of the grant date of May 13, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 6,422 shares of Advanced Medical Optics, Inc. common stock for $35.57 per share.
  • [F11]This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 843 shares of Advanced Medical Optics, Inc. common stock for $35.61 per share.
  • [F2]This option, which provided for vesting at 1/6 of the total grant at the conclusion of each calendar month in which services were performed beginning April 1, 1998, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 25,690 shares of Advanced Medical Optics, Inc. common stock for $9.83 per share.
  • [F3]This option, which was fully vested as of the grant date of March 16, 1999, was canceled pursuant to the terms of the merger agreement.
  • [F4]This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of May 19, 2000, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 3,853 shares of Advanced Medical Optics, Inc. common stock for $31.83 per share.
  • [F5]This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of May 4, 2001, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 3,853 shares of Advanced Medical Optics, Inc. common stock for $33.72 per share.
  • [F6]This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of May 3, 2002, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 3,853 shares of Advanced Medical Optics, Inc. common stock for $25.11 per share.
  • [F7]This option, which was fully vested as of the grant date of May 23, 2003, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 6,422 shares of Advanced Medical Optics, Inc. common stock for $26.57 per share.
  • [F8]The phantom stock was credited to the Reporting Person's account under the 1995 Director Option and Stock Deferral Plan and upon exercise will be settled in common stock on a 1-for-1 basis.
  • [F9]This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 1,130 shares of Advanced Medical Optics, Inc. common stock for $26.58 per share.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT